Delcath Systems, Inc.

NASDAQ:DCTH

Medical - Devices

Healthcare
$19.70 -1.91%

-$0.23 today

Market cap
$685.32M
Beta
0.52
P/E (TTM)
751.4
EPS (TTM)
$0.02
52W Low $8.12High $14.48

Volume 0.59M

Average 0.42M

DCTH Total Liabilities

Everything the company owes to creditors and other parties.

Delcath Systems, Inc.NASDAQ: DCTH

Total Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total liabilities rises 71.1% from a year ago

Total liabilities stood at $12.13M at the end of Q1 FY2026, up 71.1% from a year earlier and down 2.3% from the prior quarter. Over 3 fiscal years it compounded at -19.4% a year.

Context

  • Total liabilities amounted to 9.7% of total assets at the end of Q1 FY2026, up 1.6 pp from a year earlier.
  • Total liabilities increased in 1 of the last 3 fiscal years.

What to watch

Whether total liabilities keeps rising in the next quarterly balance sheet after a +71.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$12.13M-2.3% QoQ
Last fiscal yearDec 2025
$12.41M+58.3% YoY
Year agoMar 2025
$7.09M+71.1% since
Total Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+71.1%——
1 year+58.3%——
3-year CAGR-19.4%——
5-year CAGR——
10-year CAGR——

Total Liabilities history

USD · from the balance sheet

Latest · FY2025
12.41M USD
Year-over-year change
+58.3%
4-year CAGR
-12.5%

Total Liabilities vs competitors

How DCTH compares with its peers on the latest reported figures

  • DCTH's Mar 2026 total liabilities of $12.13M is the lowest of the 4 companies compared; the peer median is $63.33M.
  • Its year-over-year change of +71.1% is the highest of 4, against a peer median of -7.7%.
  • Total liabilities amounts to 9.7% of total assets for DCTH, versus a peer median of 58.0%.
DCTH Competitors Peer median
Total Liabilities for DCTH and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NVCRNovoCure LimitedMar 2026$457.21M -48.4%-14.8%58.0%
CATXPerspective Therapeutics, Inc.Mar 2026$63.33M +41.7%+159.0%15.4%
TLSITriSalus Life Sciences, Inc.Mar 2026$58.17M -7.7%+26.3%82.0%
DCTHDelcath Systems, Inc.Mar 2026$12.13M +71.1%-19.4%9.7%
Peer median (excluding DCTH) $63.33M-7.7%+26.3%58.0%

Competitors are the stored peer set for DCTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents22.8M7.67M12.65M32.41M43.45M
Short-term Investments0019.81M20.82M47.58M
Net Receivables44K366K483K11.06M12.94M
Inventory1.41M2M3.32M6.93M10.25M
Other Current Assets4.36M4.25M387K1.39M1.55M
Total Current Assets31.15M16.16M37.16M73.76M119.53M
Property, Plant & Equipment (Net)1.97M1.71M1.46M2.83M4.1M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets00000
Total Non-current Assets1.97M1.71M1.46M2.83M4.1M
Total Assets33.12M17.86M38.61M76.59M123.63M
Account Payables638K2.02M1.01M961K2.66M
Short-term Debt621K7.85M10.15M00
Tax Payables00000
Deferred Revenue170K0000
Other Current Liabilities2.41M1.04M1.93M3.71M4.64M
Total Current Liabilities5.95M14.74M16.45M6.14M10.95M
Long-term Debt15.01M7.84M000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities01.14M6.39M766K628K
Total Non-current Liabilities15.22M8.99M6.39M1.7M1.46M
Total Liabilities21.17M23.72M22.84M7.84M12.41M
Common Stock79K100K228K331K347K
Retained Earnings(420.98M)(457.48M)(505.16M)(531.55M)(528.85M)
Accumulated OCI18K(83K)135K82K575K
Other Stockholders Equity00000
Minority Interest00000
Total Equity11.95M(5.86M)15.78M68.75M111.22M
Total Debt16.26M15.87M10.19M1.04M936K
Net Debt(6.55M)8.2M(2.46M)(31.37M)(42.52M)

Delcath Systems, Inc.

NASDAQ:DCTH

Intrinsic Alpha fair value

Locked

Current Price

$19.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.